Ardelyx Inc (ARDX)
4.965
+0.26
(+5.41%)
USD |
NASDAQ |
Nov 15, 16:00
4.965
0.00 (0.00%)
After-Hours: 19:38
Ardelyx Gross Profit (Annual): 106.66M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 106.66M |
| December 31, 2022 | 48.04M |
| December 31, 2021 | 9.097M |
| December 31, 2020 | 7.426M |
| December 31, 2019 | 4.681M |
| Date | Value |
|---|---|
| December 31, 2018 | 2.141M |
| December 31, 2017 | 33.60M |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 24.03M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
4.681M
Minimum
2019
106.66M
Maximum
2023
35.18M
Average
9.097M
Median
2021
Gross Profit (Annual) Benchmarks
| Verve Therapeutics Inc | -- |
| United Therapeutics Corp | 2.07B |
| Zoetis Inc | 5.983B |
| NovaBay Pharmaceuticals Inc | 7.895M |
| Palatin Technologies Inc | 4.392M |